HB 2972
bill adding menstrual cramps to the low-THC cannabis list
Died in committee
Verdict: No flags
Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
Caption
relating to the medical use of low-THC cannabis by patients with certain medical conditions.
Caption from analyzed text · version I.
Summary
Dysmenorrhea qualifies starting September 1, 2025. So does premenstrual dysphoric disorder.
The bill adds conditions that cause menstrual cramps, including premenstrual dysphoric disorder and dysmenorrhea, to the list of diagnoses for which a registered Texas physician may prescribe low-THC cannabis. It touches permanent Texas residents with those conditions and the physicians who prescribe through the state's compassionate-use program. Starting September 1, 2025, those patients can qualify for low-THC cannabis prescriptions.
Labels
Labels: NEVER GOT A HEARING. Filed Feb 18, 2025 and referred to the House Public Health subcommittee on Disease Prevention & Women's & Children's Health. No public hearing. The bill died.
Receipt
The receipt
89R-HB2972 · 2025-02-18
SOLD BY
ITEM
relating to the medical use of low-THC cannabis by patients with certain medical conditions.
WHAT IT DOES
Dysmenorrhea qualifies starting September 1, 2025. So does premenstrual dysphoric disorder.
The bill adds conditions that cause menstrual cramps, including premenstrual dysphoric disorder and dysmenorrhea, to the list of diagnoses for which a registered Texas physician may prescribe low-THC cannabis. It touches permanent Texas residents with those conditions and the physicians who prescribe through the state's compassionate-use program. Starting September 1, 2025, those patients can qualify for low-THC cannabis prescriptions.
CHARGES
[ ] NONE FOUND
TOTAL
No fiscal note in the loaded record.
HISTORY
- Filed
- Read first time
- Referred to s/c on Dis Prev & Women's & Children's Health by Speaker
FILED UNDER
THE TEXT
“a condition that causes menstrual cramps, including premenstrual dysphoric disorder or dysmenorrhea;”
Bill text, introduced version (I)
The bill widens access to low-THC cannabis, but only through the licensed physician-prescription channel.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
CAMPAIGN PAID FOR BY
Donors
Not tied to this bill.
Sources
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Oct 27, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Texas REALTORS Political Action Committee$79,480.35
Texas REALTORS Political Action Committee
$79,480.35
- Cash
- $37,500.00
- Paid by others
- $41,980.35
- Total
- $79,480.35
Also funds 140 other sitting lawmakers.
Derived recipient stock · Jul 2, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Oct 31, 2024 to Oct 20, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101012300, 101032600, 101059513, 101069108, 101072533.
Texas Trial Lawyers Association PAC$55,000.00
Texas Trial Lawyers Association PAC
$55,000.00
- Cash
- $55,000.00
- Paid by others
- $0.00
- Total
- $55,000.00
Also funds 137 other sitting lawmakers.
Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 11, 2024 to Sep 21, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101012300, 101032600, 101059513, 101069108.
TexBlue Media PAC$32,511.00
TexBlue Media PAC
$32,511.00
- Cash
- $0.00
- Paid by others
- $32,511.00
- Total
- $32,511.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.
TEC account match.
Sources
Derived itemized flow · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101072533.
Missing data does not establish zero giving. Display amounts are rounded.
Texas REALTORS Political Action Committee
$79,480.35
- Cash
- $37,500.00
- Paid by others
- $41,980.35
- Total
- $79,480.35
Also funds 140 other sitting lawmakers.
Derived recipient stock · Jul 2, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Oct 31, 2024 to Oct 20, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101012300, 101032600, 101059513, 101069108, 101072533.
Texas Trial Lawyers Association PAC
$55,000.00
- Cash
- $55,000.00
- Paid by others
- $0.00
- Total
- $55,000.00
Also funds 137 other sitting lawmakers.
Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 11, 2024 to Sep 21, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101012300, 101032600, 101059513, 101069108.
TexBlue Media PAC
$32,511.00
- Cash
- $0.00
- Paid by others
- $32,511.00
- Total
- $32,511.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.
TEC account match.
Sources
Derived itemized flow · Sep 25, 2026 to Sep 27, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101072533.
Votes
No floor vote loaded for this bill.
Fiscal
No fiscal note in the loaded record.
How this was graded
Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.
Sources
Texas House · Filed Feb 18, 2025
03/20/2025 H Referred to s/c on Dis Prev & Women's & Children's Health by Speaker: Mar 20 2025 11:50AM
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:19 AM CDT. Grades, charges, quotes and corrections follow the published record.
House committee · Public Health · Final status: Died in committee
Subjects
Crimes--Drugs
Health--Other Diseases & Medical Conditions
Women
MARIHUANA
Text
The text as introduced · 220 words
89R12079 RDR-D By: Plesa H.B. No. 2972 A BILL TO BE ENTITLED AN ACT relating to the medical use of low-THC cannabis by patients with certain medical conditions. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 169.003, Occupations Code, is amended to read as follows: Sec. 169.003. PRESCRIPTION OF LOW-THC CANNABIS. A physician described by Section 169.002 may prescribe low-THC cannabis to a patient if: (1) the patient is a permanent resident of the state; (2) the physician complies with the registration requirements of Section 169.004; and (3) the physician certifies to the department that: (A) the patient is diagnosed with: (i) epilepsy; (ii) a seizure disorder; (iii) multiple sclerosis; (iv) spasticity; (v) amyotrophic lateral sclerosis; (vi) autism; (vii) cancer; (viii) an incurable neurodegenerative disease; (ix) post-traumatic stress disorder; [ or ] (x) a condition that causes menstrual cramps, including premenstrual dysphoric disorder or dysmenorrhea; or (xi) a medical condition that is approved for a research program under Subchapter F, Chapter 487, Health and Safety Code, and for which the patient is receiving treatment under that program; and (B) the physician determines the risk of the medical use of low-THC cannabis by the patient is reasonable in light of the potential benefit for the patient. SECTION 2. This Act takes effect September 1, 2025.